Presalvage International Staging System Stage and Other Important Outcome Associations in CD34+-Selected Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Presalvage International Staging System Stage and Other Important Outcome Associations in CD34+-Selected Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma

Published:2020-01 Issue:1 Volume:26 Page:58-65
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Bryant Adam R.,Hilden Patrick,Giralt Sergio,Chung David J.,Maloy Molly,Landau Heather,Landgren Ola,Scordo Michael,Shah Gunjan,Smith Eric L.,O'Reilly Richard J.,Perales Miguel-Angel,Koehne Guenther

Funder

National Institutes of Health

National Cancer Institute

Ottawa Hospital

Ottawa Hospital Research Institute

Amgen

Celgene

Miltenyi Biotec

Food and Drug Administration

Multiple Myeloma Research Foundation

International Myeloma Foundation

Leukemia and Lymphoma Society

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference19 articles.

1. Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study;Kumar;Leukemia,2017

2. American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma

3. CD34-selected allogeneic hematopoietic stem cell transplantation for patients with relapsed, high-risk multiple myeloma;Smith;Biol Blood Marrow Transplant,2016

4. High-risk multiple myeloma: definition and management;Joseph;Clin Lymphoma Myeloma Leuk,2017

5. International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma;Kumar;Lancet Oncol,2016

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sysmex XN-HPC: study of reference intervals and clinical decision limits in healthy allogeneic donors mobilised with G-CSF;Clinical and Experimental Medicine;2024-08-24

2. Efficacy and survival outcome of allogeneic stem-cell transplantation in multiple myeloma: meta-analysis in the recent 10 years;Frontiers in Oncology;2024-07-31

3. Autologous and Allogeneic Stem Cell Transplantation as Salvage Treatment Options for Relapsed/Refractory Multiple Myeloma: A Single-center Experience over 20 Years;Anticancer Research;2022-12

4. Current Role of Allogeneic Stem Cell Transplantation in Multiple Myeloma;Oncology and Therapy;2022-04-04

5. Allogeneic Stem Cell Transplantation in Multiple Myeloma;Cancers;2021-12-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3